A RANDOMIZED, CONTROLLED, OPEN LABEL STUDY TO EVALUATE THE EFFECT OF EVEROLIMUS ON FIBROSIS PROGRESSION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: THE REVERT STUDY

被引：0
|
作者：
Villamil, F. [1 ]
Gadano, A. [2 ]
Zingale, F. [3 ]
Perez, R. R. [4 ]
Yantorno, S. [1 ]
Otero, A.
Avagnina, A. [5 ]
机构：
[1] Fdn Favaloro, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[3] Inst Cardio Vasc Rosario, Rosario, Argentina
[4] Hosp Italiano, Mendoza, Argentina
[5] CEMIC, Buenos Aires, DF, Argentina
来源：
LIVER TRANSPLANTATION | 2009年 / 15卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S218 / S219
页数：2
相关论文
共 50 条
  • [1] Effect of Everolimus on Fibrosis Progression in Liver Transplant Patients with Recurrent Hepatitis C - Results from the REVERT Study.
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Otero, A.
    Wang, Y.
    Lopez, P.
    Mastai, R.
    LIVER TRANSPLANTATION, 2012, 18 : S98 - S99
  • [2] Progression of Fibrosis in Maintenance Liver Transplant Recipients with HCV Recurrence Converted to Everolimus: Results of a Multicenter, Randomized, Controlled Study
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Wang, Y.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 84 - 84
  • [3] A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
    Davis, GL
    Nelson, DR
    Terrault, N
    Pruett, TL
    Schiano, TD
    Fletcher, CV
    Sapan, CV
    Riser, LN
    Li, YF
    Whitley, RJ
    Gnann, JW
    LIVER TRANSPLANTATION, 2005, 11 (08) : 941 - 949
  • [4] Result of Everolimus Treatment on Fibrosis Progression in Maintenance Liver Transplant Patients with Recurrent Hepatitis C
    Villamil, F.
    Gadano, A.
    Zingale, F.
    Perez, R.
    Gil, O.
    Yantorno, S.
    Mastai, R.
    Otero, A.
    Dong, G.
    Lopez, P.
    TRANSPLANTATION, 2012, 94 (10) : 9 - 9
  • [5] Effect of donor liver steatosis on progression of recurrent hepatitis C in liver transplant recipients
    Katabi, N
    Onaca, N
    Morkowski, J
    Thomas, M
    Goldstein, R
    Watkins, D
    Sanchez, E
    Levy, M
    Klintmalm, G
    Netto, G
    MODERN PATHOLOGY, 2003, 16 (01) : 279A - 279A
  • [6] Effect of donor liver steatosis on progression of recurrent hepatitis C in liver transplant recipients
    Katabi, N
    Onaca, N
    Morkowski, J
    Thomas, M
    Goldstein, R
    Watkins, D
    Sanchez, E
    Levy, M
    Klintmalm, G
    Netto, G
    LABORATORY INVESTIGATION, 2003, 83 (01) : 279A - 279A
  • [7] Effect of Interferon On Fibrosis Progression Among Liver Transplant Recipients With Hepatitis C
    Habib, C. S.
    Meister, E.
    Rana, A.
    Obaid, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 708 - 708
  • [8] Effect of Interferon On Fibrosis Progression Among Liver Transplant Recipients With Hepatitis C.
    Habib, S.
    Meister, E.
    Rana, A.
    Obaid, S.
    TRANSPLANTATION, 2014, 98 : 708 - 708
  • [9] Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression
    Lionetti, Raffaella
    Tisone, Giuseppe
    Palmieri, Giampiero
    Almerighi, Cristiana
    Anselmo, Alessandra
    Tariciotti, Laura
    Lenci, Ilaria
    De Luca, Linda
    Monaco, Andrea
    Angelico, Mario
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (04) : 297 - 303
  • [10] Progression of fibrosis and interferon treatment in liver transplant recipients with hepatitis C infection
    Habib, Shahid
    Chang, Chung-Chou H.
    Ahmad, Jawad
    Sass, David
    Shaw-Stiffel, Thomas
    Demetris, Anthony J.
    De Vera, Michael
    Fontes, Paulo
    Marcos, Amadeo
    Shaikh, Obaid S.
    HEPATOLOGY, 2006, 44 (04) : 320A - 320A
12345